Cargando…
Novel Drug Interaction index and Risk of Mortality in Older Patients With Atrial Fibrillation Receiving Non Vitamin K Oral Anticoagulants (NOEL Drug)
Drug interactions with novel oral anticoagulants (NOACs) may decrease their advantages. We aimed to explore the drug interaction rates with NOACs and impacts of drug interaction index (DII) on mortality among older patients with atrial fibrillation (AF). In this retrospective cohort study, we enroll...
Autor principal: | Ersoy, İbrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642067/ https://www.ncbi.nlm.nih.gov/pubmed/34541922 http://dx.doi.org/10.1177/10760296211038685 |
Ejemplares similares
-
Impact of drug interactions with direct oral anticoagulants on mortality in elderly with atrial fibrillation during the COVID-19 pandemic
por: Ersoy, İbrahim, et al.
Publicado: (2023) -
Impact of drug interactions with direct oral anticoagulants on mortality in elderly with atrial fibrillation during the COVID-19 pandemic
por: Ersoy, İbrahim, et al.
Publicado: (2023) -
Drug-drug interactions in atrial fibrillation patients receiving direct oral anticoagulants
por: Lee, Ji Yun, et al.
Publicado: (2021) -
Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
por: Giugliano, Robert P
Publicado: (2022) -
Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
por: Zulkifly, Hanis, et al.
Publicado: (2022)